Emotional stress reduces effectiveness of prostate cancer therapies in animal model
Not surprisingly, a cancer diagnosis creates stress. And patients with prostate cancer show higher levels of anxiety compared to other cancer patients. A new study by researchers at Wake Forest Baptist Medical Center indicates that stress is not just an emotional side effect of the diagnosis; it also can reduce the effectiveness of prostate cancer drugs and accelerate the development of prostate cancer.
The findings are published in the February issue of the Journal of Clinical Investigation.
The Wake Forest Baptist team, headed by George Kulik, D.V.M., Ph.D., associate professor of cancer biology, tested the effects of behavioral stress in two different mouse models of prostate cancer.
One model used mice that were implanted with human prostate cancer cells and treated with a drug that is currently in clinical trial for prostate cancer treatment. When the mice were kept calm and free of stress, the drug destroyed prostate cancer cells and inhibited tumor growth. However, when the mice were stressed, the cancer cells didn't die and the drug did not inhibit tumor growth.
In the second model, mice genetically modified to develop prostate cancer were used. When these mice were repeatedly stressed, the size of prostate tumors increased. When the mice were treated with bicalutamide, a drug currently used to treat prostate cancer, their prostate tumors decreased in size. However, if mice were subjected to repeated stress, the prostate tumors didn't respond as well to the drug.
After analyzing the data, the Wake Forest Baptist researchers identified the cell signaling pathway by which epinephrine, a hormone also known as adrenaline, sets off the cellular chain reaction that controls cell death. Considering that prostate cancer diagnosis increases stress and anxiety levels, stress-induced activation of the signaling pathway that turns off the cell death process may lead to a vicious cycle of stress and cancer progression, Kulik said.
Yet in both models in which the mice were given beta-blocker, stress did not promote prostate tumor growth. Beta-blocker is a drug that inhibits the activation of anti-death signaling by epinephrine.
"Providing beta-blockers to prostate cancer patients who had increased epinephrine levels could improve the effectiveness of anti-cancer therapies," Kulik said. "Our findings could be used to identify prostate cancer patients who will benefit from stress reduction or from pharmacological inhibition of stress-inducing signaling."
The researchers now plan to test the same signaling mechanism that was identified in mice to determine if it also works in the same way in human prostates, Kulik said.
"We are at the very beginning of understanding complex stress-cancer interactions with multifaceted responses to stress that affect cancer cells, tumor microenvironment, and the organism overall," he said. "We hope that components of this signaling pathway could be used as biomarkers to predict whether and how a given tumor will respond to stress and anti-stress therapies."
- Predicting higher risk for prostate cancer diagnosisTue, 26 May 2009, 19:38:01 EDT
- New tool allows for an alternate method of prostate cancer diagnosisFri, 1 Apr 2011, 0:34:00 EDT
- New targeted therapy effective in treating advanced prostate cancerWed, 14 Apr 2010, 18:46:05 EDT
- Prostate cancer therapy increases risk of fractures and cardiovascular-related deathMon, 27 Apr 2009, 0:30:12 EDT
- New drug shows promise in treating drug-resistant prostate cancerFri, 10 Apr 2009, 10:24:39 EDT
Articles on the same topic
- Study finds eating deep-fried food is associated with an increased risk of prostate cancerMon, 28 Jan 2013, 16:19:41 EST
- Fried Food Linked To Increased Risk Of Prostate Cancerfrom Scientific BloggingMon, 28 Jan 2013, 15:54:42 EST
- Eating deep-fried food linked to increased risk of prostate cancerfrom Science DailyMon, 28 Jan 2013, 15:35:20 EST
- Emotional stress reduces effectiveness of prostate cancer therapies in animal modelfrom Science DailySat, 26 Jan 2013, 14:01:23 EST
- Emotional stress reduces effectiveness of prostate cancer therapies in animal modelfrom Science BlogSat, 26 Jan 2013, 8:30:56 EST
- Follow-up to REDUCE study shows low rate of prostate cancer diagnosisfrom Science DailyTue, 22 Jan 2013, 19:30:39 EST
Latest Science NewsletterGet the latest and most popular science news articles of the week in your Inbox! It's free!
Learn more about
Check out our next project, Biology.Net
From other science news sites
Popular science news articles
- Mysteries of Earth's radiation belts uncovered by NASA twin spacecraft
- Fledgling supernova remnant reveals neutron star's secrets
- Sea level rise and shoreline changes are lead influences on floods from tropical cyclones
- CU-Boulder-led team finds first evidence of primates regularly sleeping in caves
- New fossil species found in Mozambique reveals new data on ancient mammal relatives
- Stanford study suggests why, in some species, mere presence of males shortens females' lifespan
- 'Spooky action' builds a wormhole between 'entangled' quantum particles
- Fruit flies with better sex lives live longer
- The mystery of neutron stars heats up
- New report calls for attention to abrupt impacts from climate change